RKRichard Kellersmann

Richard Kellersmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Richard Kellersmann has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical implications of fracture-associated vascular damage in extremity and pelvic trauma

    by F. Gilbert, C. Schneemann, C. J. Scholz, R. Kickuth, R. H. Meffert, R. Wildenauer, U. Lorenz, R. Kellersmann, A. Busch

    Vascular damage in polytrauma patients is associated with high mortality and morbidity. Therefore, specific clinical implications of vascular damage with fractures in major trauma patients are reassessed. This comprehensive nine-year retrospective single center cohort study analyzed demography, laboratory, treatment and outcome data from 3689 patients, 64 patients with fracture-associated vascular injuries were identified and were compared to a control group. Results: Vascular damage occurred in 7% of patients with upper and lower limb and pelvic fractures admitted to the trauma room. Overall survival was 80% in pelvic fracture and 97% in extremity fracture patients and comparable to non-vascular trauma patients. Additional arterial damage required substantial fluid administration and was visible as significantly anemia and disturbed coagulation tests upon admission. Open procedures were done in over 80% of peripheral extremity vascular damage. Endovascular procedures were predominant (87%) in pelvic injury. Vascular damage is associated with high mortality rates especially in combination with pelvic fractures. Initial anemia, disturbed coagulation tests and the need for extensive pre-clinical fluid substitution were observed in the cohort with vascular damage. Therefore, fast diagnosis and early interventional and surgical procedures are necessary to optimize patient-specific outcome.


  • Open Access

    Interdisciplinary complication management of dislodged lumbar interbody spacer in pulmonary artery

    by Andreas Kunz, Thorsten Klink, Stefan Köhler, Richard Kellersmann, Christian Markus, Thorsten Bley, Ralph Kickuth

    We report the case of an intraoperatively dislodged transforaminal lumbar interbody fusion spacer with creation of a traumatic arteriovenous fistula and device migration to the pulmonary artery. Successful minimally invasive angiographic retrieval of the spacer is discussed with special reference to angiographic and surgical treatment strategies and pitfalls.

  • Proximal occlusion of unaffected internal iliac artery versus distal occlusion of aneurysmatic internal iliac artery prior to EVAR: a comparative evaluation of efficacy and clinical outcome

    by Alexander Dierks, Alexander Sauer, Franziska Wolfschmidt, Nicole Hassold, Richard Kellersmann, Thorsten A Bley, Ralph Kickuth

    Objective:Occlusion of the internal iliac artery (IIA) may be necessary prior to endovascular aneurysm repair (EVAR) to prevent endoleak Type II. We compared efficacy and clinical outcome after proximal occlusion of an unaffected IIA (ProxEmbx) using an Amplatzer vascular plug (AVP) I vs distal occlusion of aneurysmatic IIA with coils and plugs (DistEmbx).Methods:Between 2009 and 2012, 22 patients underwent EVAR. In 9 patients with unaffected IIA, occlusion was performed by a single AVP. In 13 patients with aneurysmatic IIA, more distal embolization (DistEmbX) was conducted by using several coils and additional AVPs. Retrospectively, technical success, clinical outcome and complications were evaluated.Results:Embolization of the IIA was successful in all patients. Three patients with more DistEmbX of aneurysmatic IIAs suffered from new onset of sexual dysfunction after occlusion without statistically significant difference (p > 0.05). Transient buttock claudication was observed in three patients in each g...


  • Timing zur Shunt-Anlage

    by R. Kellersmann


  • Open Access

    Aneurysm miRNA Signature Differs, Depending on Disease Localization and Morphology

    by Albert Busch, Martin Busch, Claus-Jürgen Scholz, Richard Kellersmann, Christoph Otto, Ekaterina Chernogubova, Lars Maegdefessel, Alma Zernecke, Udo Lorenz

    Limited comprehension of aneurysm pathology has led to inconclusive results from clinical trials. miRNAs are key regulators of post-translational gene modification and are useful tools in elucidating key features of aneurysm pathogenesis in distinct entities of abdominal and popliteal aneurysms. Here, surgically harvested specimens from 19 abdominal aortic aneurysm (AAA) and 8 popliteal artery aneurysm (PAA) patients were analyzed for miRNA expression and histologically classified regarding extracellular matrix (ECM) remodeling and inflammation. DIANA-based computational target prediction and pathway enrichment analysis verified our results, as well as previous ones. miRNA-362, -19b-1, -194, -769, -21 and -550 were significantly down-regulated in AAA samples depending on degree of inflammation. Similar or inverse regulation was found for miR-769, 19b-1 and miR-550, -21, whereas miR-194 and -362 were unaltered in PAA. In situ hybridization verified higher expression of miR-550 and -21 in PAA compared to AAA and computational analysis for target genes and pathway enrichment affirmed signal transduction, cell-cell-interaction and cell degradation pathways, in line with previous results. Despite the vague role of miRNAs for potential diagnostic and treatment purposes, the number of candidates from tissue signature studies is increasing. Tissue morphology influences subsequent research, yet comparison of distinct entities of aneurysm disease can unravel core pathways.


  • Shunt-induzierte Handischämie

    by Farzin Adili, Richard Kellersmann

    Die Therapie der Shunt-induzierten Handischämie wird zukünftig eine zunehmende Bedeutung erfahren. Der Anstieg der Anzahl älterer Hämodialysepatienten mit einem höheren Anteil an Diabetikern wird vermehrt Patienten mit Risikofaktoren für eine Shunt-induzierte Handischämie bedingen (proximal gelegene Anastomose, vorbestehende Gefäßveränderungen). Einheitliche Empfehlungen zur Wahl des Behandlungsverfahrens können nicht gegeben werden. Auch die DRIL-Prozedur, die oftmals in der neueren Literatur als Standardverfahren propagiert wird, ist nur Teil eines Armamentariums der Therapie der Shunt-induzierten Handischämie. Entscheidend für die Wahl des Therapieverfahrens ist das Erkennen der individuell bei den einzelnen Patienten zugrunde liegenden Pathomechanismen der Shunt-induzierten Handischämie. Faktoren wie die geschätzte Lebenserwartung des Patienten und die Beeinflussung der Lebensqualität durch das Operationsverfahren sollten bei der Indikationsstellung Berücksichtigung finden. Technische Weiterentwicklungen bei der Identifizierung und Überwachung der hämodynamischen Veränderungen nach Anlage eines arteriovenösen Shunt werden das Verständnis der Ätiologie der Shunt-induzierten Handischämie erweitern, die differenzierte Verfahrenswahl zur Therapie der Shunt-induzierten Handischämie unterstützen und den zu erwartenden Einfluss auf die Symptombeseitigung und den Shunt-Erhalt besser abschätzen lassen. Sicherlich gehört die Behandlung der Shunt-induzierten Handischämie in die Hand des erfahrenen Shunt-Chirurgen, da die Qualität der von ihm durchgeführten Maßnahmen das Outcome des Hämodialysepatienten wesentlich beeinflussen kann.

  • Stenosen von arteriovenösen Dialysefisteln

    by R. Kellersmann, R. Kickuth